The outcomes revealed a notable rise in the quantity of Cal-62 and TPC-1 apoptotic cells following ETS2 overexpression, indicating that ETS2 enhances apoptosis in thyroid cancer cells (Figs 6A, 6B). Here, ETS2 is linked to thyroid gland carcinoma.